Table 4.
L.Pm (%) | MAR (µm/day) | BFR/B.Pm (µm/day × 100) | |
---|---|---|---|
Periosteal Surface | |||
Male Control | 21.6 ± 6.5a,b,c | 1.38 ± 0.32 | 32.3 ± 16.2b,c |
Male ALSKO | 28.0 ± 6.8b,c | 1.29 ± 0.29 | 35.6 ± 7.9b,c |
Female Control | 28.4 ± 8.5b,c | 1.43 ± 0.28 | 41.1 ± 14.5b,c |
Female ALSKO | 25.1 ± 2.7b,c | 1.44 ± 0.16 | 35.8 ± 4.1b,c |
Endosteal Surface | |||
Male Control | 10.8 ± 7.5a,b,c | 1.40 ± 0.10 | 25.1 ± 3.9b,c |
Male ALSKO | 41.0 ± 12.7b | 1.58 ± 0.81 | 62.2 ± 27.0b |
Female Control | 56.1 ± 18.1 | 1.39 ± 0.35 | 80.6 ± 37.6 |
Female ALSKO | 68.3 ± 5.8 | 1.55 ± 0.15 | 105.6 ± 14.1 |
Statistically different from male ALSKO endosteal surface.
Statistically different from female ALSKO endosteal surface.
Statistically different from female control endosteal surface.